close modal

How Can We Help You?

Accent Lines

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Kaleo Logo

News

Media Contact

Caryn Foster Durham
Senior Director, Corporate Communications
(804) 256-7766
media.inquiries@kaleo.com

Woman walking in hallway
Media Contact

Caryn Foster Durham
Senior Director, Corporate Communications
(804) 256-7766
media.inquiries@kaleo.com

News Archive

Accent Lines
September 8, 2016

Kaléo Presents Studies at PAINWeek 2016 Comparing Naloxone Intramuscular Injection and Naloxone Intranasal Administration
March 28, 2016

More than 1000 Lives Reported Saved with Help of EVZIO® (naloxone HCl injection) Auto-injectors
January 25, 2016

Kaléo Announces the Award of its 100th Patent
January 12, 2016

More than 600 Lives Reported Saved Since Launch of the “Kaléo Cares” EVZIO® (naloxone HCl injection) Auto-injector Donation Program
October 5, 2015

Chelsea Laliberte, Co-Founder of Live4Lali, Named Recipient of the First Annual Kaléo Cares Award
September 29, 2015

Kaléo to Donate 50,000 EVZIO® (naloxone HCl injection) Auto-Injectors in Honor of the UNITE to Face Addiction Rally
September 2, 2015

New Campaign Urges It’s Time “America Starts Talking” More Openly About Safe Prescription Opioid Pain Management
August 31, 2015

More than 100 Lives Reported Saved Since Launch of the “kaleo Cares” EVZIO® (naloxone HCl injection) Donation Program
January 26, 2015

Kaléo and the Clinton Foundation’s Health Matters Initiative
 Unite to Reduce Prescription Opioid-Related Deaths
January 16, 2015

Police Reverse First Opioid Overdose Using EVZIO® (naloxone HCl injection) Provided through Kaléo Cares Donation Program
October 27, 2014

Kaléo Supports Opioid Overdose Emergency Treatment Efforts with EVZIO™ (naloxone hcl injection) Donations to Local Law Enforcement Agencies
July 10, 2014

EVZIO™ (naloxone HCl injection) Auto-Injector Now Available in the United States for the Emergency Treatment of Opioid Overdose
April 7, 2014

Kaléo announces $150 million debt financing to support commercialization of EVZIO™
April 3, 2014

FDA Approves Kaleo’s EVZIO™ for the Emergency Treatment of Opioid Overdose
January 6, 2014

Intelliject, Inc. announces name change to Kaléo
November 14, 2013

Intelliject, Inc. wins prestigious medication safety award
May 29, 2012

Intelliject, Inc. announces $15 million debt financing to accelerate targeted pipeline development
1 2 3